Market Research - Acceptability Trial for a New PKU Amino Acid Based Protein Substitute

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-01

Study Completion Date

2018-09-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to demonstrate that a new protein substitute is acceptable and well tolerated in children with PKU.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

SNAP: Study Nutrients in Adult PKU

NCT03858101

Phenylketonuria

COMPLETED

Effects of Synergy on Nutrient Intake and Acceptability in Phenylketonuria (PKU)

NCT03777826

Phenylketonurias

COMPLETED NA

Evaluation of Low Phenylalanine Formulas

NCT06332105

Phenylketonurias

ACTIVE_NOT_RECRUITING NA

Evaluating the Efficacy of PKU Synergy in Patients Expressing Phenylketonuria or Hyperphenylalaninemia

NCT03167697

Phenylketonurias Hyperphenylalaninaemia, Type I

COMPLETED NA

Safety and Tolerability of RTX-134 in Adults With Phenylketonuria

NCT04110496

Phenylketonurias

TERMINATED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

PKU Phenylketonurias Inborn Errors of Metabolism Metabolic Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PKU Motion

amino acid based protein substitute

Group Type EXPERIMENTAL

Motion

Intervention Type DIETARY_SUPPLEMENT

Amino acid based protein substitute

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Motion

Amino acid based protein substitute

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of PKU or PKU variant requiring a phenylalanine-free protein substitute
* Subjects who are already taking a phenylalanine-free protein substitute and are willing to try the study product for 7 days
* Patients aged 3 years of age to adulthood
* Written informed consent obtained from parental caregiver

Exclusion Criteria

* Presence of serious concurrent illness
* Investigator's uncertainty about the willingness or ability of the patient to comply with the protocol requirements
* Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study.
* Any patients having taken antibiotics over the previous 2 weeks leading up to the study.
* Patients less than 3 years of age.

Minimum Eligible Age

3 Years

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No